Ekso Bionics Holdings, Inc. (EKSO)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Medical Products	12.80M	17.93M	18.28M	-	-
Medical Products Growth	-28.60%	-1.94%	-	-	-
EksoWorks	-	-	-	1.08M	1.50M
EksoWorks Growth	-	-	-	-27.67%	83.33%
EksoHealth	-	-	-	11.83M	9.75M
EksoHealth Growth	-	-	-	21.33%	20.88%
Total	12.80M	17.93M	18.28M	12.91M	11.25M
Total Growth	-28.60%	-1.94%	41.57%	14.81%	26.62%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States	7.43M	9.71M	12.50M	6.56M	6.45M
United States Growth	-23.50%	-22.30%	90.64%	1.64%	9.67%
Other Americas	72.00K	421.00K	495.00K	252.00K	127.00K
Other Americas Growth	-82.90%	-14.95%	96.43%	98.43%	60.76%
France	1.43M	3.01M	181.00K	-	-
France Growth	-52.43%	1560.77%	-	-	-
Other Europe, Middle East, and Africa	2.36M	2.94M	3.58M	1.94M	2.08M
Other Europe, Middle East, and Africa Growth	-19.55%	-18.08%	84.46%	-6.77%	145.47%
Asia Pacific	1.51M	1.85M	1.52M	2.25M	1.26M
Asia Pacific Growth	-18.65%	21.79%	-32.61%	79.32%	5.81%
Poland	-	-	-	904.00K	-
Germany	-	-	-	1.00M	1.33M
Germany Growth	-	-	-	-24.49%	50.11%
Total	12.80M	17.93M	18.28M	12.91M	11.25M
Total Growth	-28.60%	-1.94%	41.57%	14.81%	26.62%

Source: S&P Global Market Intelligence.